Drug Shortage Report for INHIBACE PLUS

Last updated on 2024-07-02 History
Report ID 230712
Drug Identification Number 02181479
Brand name INHIBACE PLUS
Common or Proper name Hydrochlorothiazide / Cilazapril
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CILAZAPRIL
Strength(s) 12.5MG 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 28 tablets
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-07-01
Actual start date
Estimated end date 2024-09-20
Actual end date
Shortage status Actual shortage
Updated date 2024-07-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-07-02 English Compare
v3 2024-06-17 French Compare
v2 2024-06-17 English Compare
v1 2024-06-17 English Compare

Showing 1 to 4 of 4